壹生资讯-2019 CSCO-CMT中国临床肿瘤学年度进展评选活动开始啦！

您已通过HCP身份认证和信息审核

(

2019 CSCO-CMT中国临床肿瘤学年度进展评选活动开始啦！

2019-12-13作者：Aurora资讯

2019 CSCO CMT中国临床肿瘤学年度进展

时光荏苒，2019年已接近尾声，又到了年终总结、年度盘点的重要时刻。回首2019，中国临床肿瘤学专家学者活跃在各大国际舞台，牵头开展的临床研究也如火如荼，多项研究结果已发表在各大学术期刊，展示了我们的“好研究”，发出了我们的“好声音”。值此辞旧迎新的重要时刻，中国临床肿瘤学会（CSCO）与《中国医学论坛报》社（CMT）再度携手，联合举办第8届“CSCO-CMT中国临床肿瘤学年度进展评选”活动。
不同于往年，本次候选研究不仅包括2019年已发表在国际期刊的22项临床研究，更有7项发表在国内优质期刊的临床研究，我们将采用评委组专家打分和网络读者投票的联合评分模式，选出前十项研究，成为2019 CSCO-CMT中国临床肿瘤学十大年度进展。
最终评选结果将于2020年1月2日在“壹生”APP、“中国医学论坛报今日肿瘤”公众号和报纸同步公布！

截屏2019-12-11下午11.06.45.png

请结合研究的创新程度、能否改变临床实践、中国患者可及性和国际影响力四方面综合评估，选出你心中的“十大”。

投票时间

即日起至2019年12月27日17:00

投票规则

每位用户每天可以投2次，在“中国医学论坛报今日肿瘤”公众号微信端点开链接可以投1次；下载中国医学论坛报社官方APP“壹生”，成功注册可以在“壹生”APP端投票链接投1次。每次投票可选择1-10项研究。

二十九项候选研究简介

点击→【候选研究1-7】

点击→【候选研究8-14】

点击→【候选研究15-21】

点击→【候选研究22-28（7项中文研究）】

点击→【候选研究29】

编辑｜刘婷（中国医学论坛报）

{"attendFlag":0,"createTime":1576166046000,"dayEndTime":"23:45","dayStartTime":"00:00","endTime":1577376000000,"hideVotenum":false,"id":110097349,"isBindWx":0,"isOpenValidate":0,"items":[{"createTime":1576166046000,"filepathIds":"","id":2383,"imagePattern":0,"images":[],"isMultiple":1,"isNecessary":0,"maxChoicesNum":10,"minChoicesNum":1,"options":[{"createTime":1576166046000,"description":"通讯作者：中山大学孙逸仙纪念医院  唐亚梅\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Jan 10;37(2):135-143","filepathIds":"","id":9722,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"普瑞巴林对头颈癌患者放疗相关神经性疼痛的影响：一项随机对照试验","userCount":12,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：天津医科大学肿瘤医院  陈可欣\r\n研究出处：《柳叶刀·肿瘤学》Lancet Oncol.2019 Feb;20(2):193-201","filepathIds":"","id":9723,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"使用深度卷积神经网络模型的超声图像进行甲状腺癌的诊断：回顾性、多队列、诊断研究","userCount":108,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：中国医学科学院肿瘤医院  李晔雄\r\n研究出处：《柳叶刀·肿瘤学》Lancet Oncol.2019 Mar;20(3):352-360","filepathIds":"","id":9724,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"大分割放疗在高危乳腺癌患者中疗效不劣于常规分割放疗","userCount":15,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：武汉大学中南医院  谢丛华；杜克-新加坡国立大学医学院  Melvin L. K. Chua\r\n研究出处：《肿瘤学年鉴》Ann Oncol. 2019 Apr 1;30(4):637-643","filepathIds":"","id":9725,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"抗表皮生长因子受体（EGFR）单克隆抗体联合顺铂和5-氟尿嘧啶治疗根治性放射治疗后转移性鼻咽癌患者","userCount":6,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：北京协和医院  李剑\r\n研究出处：《白血病》Leukemia.2019 Apr;33(4):1023-1029","filepathIds":"","id":9726,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"POEMS综合征的最佳一线治疗方法是什么：自体移植，美法仑和地塞米松，或来那度胺和地塞米松？","userCount":890,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：厦门大学  张军  夏宁邵；中国医学科学院肿瘤医院  乔友林\r\n研究出处：《美国国立癌症研究所杂志》J Natl Cancer Inst. 2019 May 11. pii: djz074","filepathIds":"","id":9727,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"大肠杆菌生产的二价人乳头瘤病毒疫苗的功效，安全性和免疫原性：一项随机临床试验的中期分析","userCount":7,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：中山大学肿瘤防治中心  袁中玉\r\n研究出处：《美国国立癌症研究所杂志》J Natl Cancer Inst. 2019 May 15. pii: djz086","filepathIds":"","id":9728,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"神经节苷脂治疗乳腺癌患者紫杉类药物周围神经毒性的随机临床研究","userCount":17,"userId":2483213},{"createTime":1576166046000,"description":"通讯作者：中国人民解放军总医院  韩为东\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019Jun 10;37(17):1479-1489","filepathIds":"","id":9729,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"在抗PD-1抗体卡瑞利珠单抗治疗复发/难治性经典霍奇金淋巴瘤中添加低剂量地西他滨","userCount":9,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：解放军总医院第五医学中心  江泽飞\r\n研究出处：《柳叶刀·肿瘤学》Lancet Oncol. 2019 Jun;20(6):806-815","filepathIds":"","id":9730,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"西达本胺加依西美坦治疗绝经后晚期激素受体阳性乳腺癌患者：一项随机，双盲，安慰剂对照的3期临床试验","userCount":9,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中山大学肿瘤防治中心  石明\r\n研究出处：《美国医学会杂志·肿瘤学》JAMA Oncol.2019 Jul 1;5(7):953-960","filepathIds":"","id":9731,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"对比索拉非尼联合肝动脉输注奥沙利铂，氟尿嘧啶和白细胞介素与索拉非尼单药治疗肝细胞癌伴门静脉侵犯","userCount":12,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：复旦大学附属肿瘤医院  赵快乐\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Jul 10;37(20):1695-1703","filepathIds":"","id":9732,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"对比紫杉醇联合5-FU与顺铂联合5-FU同期放化疗在局部晚期食管鳞状细胞癌患者中的疗效","userCount":3,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：复旦大学中山医院  樊嘉；第二军医大学东方肝胆外科医院  王红阳；美国西北大学  Wei Zhang；芝加哥大学  Chuan He\r\n研究出处：《消化道》Gut. 2019 Jul 29. pii: gutjnl-2019-318882","filepathIds":"","id":9733,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"在循环无细胞DNA中的5-羟甲基胞嘧啶全基因组测序是一种无创的肝癌早期检测方法","userCount":5,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：北京大学肿瘤医院  郭军\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019Aug 12:JCO1900210","filepathIds":"","id":9734,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"阿昔替尼联合特瑞普利单抗，一种针对PD-1的人源化免疫球蛋白G4单克隆抗体，用于转移性黏膜黑素瘤患者","userCount":5,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：上海东方肝胆外科医院  程树群\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Aug 20;37(24):2141-2151","filepathIds":"","id":9735,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"伴有门静脉肿瘤血栓的可切除肝细胞癌的新辅助三维共形放射疗法：一项随机，开放标签，多中心对照研究","userCount":4,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：广东省人民医院  吴一龙\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Sep 1;37(25):2235-2245","filepathIds":"","id":9736,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"厄洛替尼对比吉西他滨联合顺铂作为IIIA-N2期EGFR突变型非小细胞肺癌新辅助治疗","userCount":6,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：同济大学附属上海东方医院  郭晔\r\n研究出处：《肿瘤学年鉴》Ann Oncol. 2019 Sep 10. pii: mdz388","filepathIds":"","id":9737,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"阿法替尼对比甲氨蝶呤在基于铂类治疗后头颈部复发或转移性鳞状细胞癌患者的二线治疗","userCount":2,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中山大学肿瘤防治中心  马骏\r\n研究出处：《新英格兰医学杂志》N Engl J Med. 2019 Sep 19;381(12):1124-1135","filepathIds":"","id":9738,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"吉西他滨联合顺铂诱导化疗治疗鼻咽癌","userCount":14,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中山大学附属第六医院  汪建平\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Sep 26:JCO1802309","filepathIds":"","id":9739,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"改良mFOLFOX6联合/不联合放疗对比氟尿嘧啶联合放疗治疗局部晚期直肠癌的疗效","userCount":3,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中山大学肿瘤防治中心  徐瑞华\r\n研究出处：《柳叶刀·肿瘤学》Lancet Oncol. 2019 Oct 4. pii: S1470-2045(19)30637-0","filepathIds":"","id":9740,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"人工智能实时辅助内镜早期诊断上消化道肿瘤：一项多中心、病例对照、诊断性研究","userCount":13,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中国医学科学院肿瘤医院  徐兵河\r\n研究出处：《临床肿瘤学杂志》J Clin Oncol. 2019 Oct 10;37(29):2610-2619","filepathIds":"","id":9741,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"吡咯替尼或拉帕替尼联合卡培他滨治疗前期使用过紫杉类，蒽环类和/或曲妥珠单抗的HER2阳性转移性乳腺癌","userCount":5,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：复旦大学附属肿瘤医院  邵志敏\r\n研究出处：《美国医学会杂志·肿瘤学》JAMA Oncol. 2019 Oct 24","filepathIds":"","id":9742,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"帕博利珠单抗，曲妥珠单抗和多西紫杉醇对早期或局部晚期亚洲ERBB2阳性乳腺癌患者的疗效，安全性和耐受","userCount":4,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：浙江大学附属邵逸夫医院  潘宏铭\r\n研究出处：中华肿瘤杂志, 2019,41(2) : 152-153","filepathIds":"","id":9743,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"埃克替尼治疗表皮生长因子受体敏感突变型高龄晚期非小细胞肺癌患者的临床疗效","userCount":3,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：贵州省人民医院  易韦\r\n研究出处：中华肿瘤杂志, 2019,41(2) : 118-123","filepathIds":"","id":9744,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"金龙胶囊联合新辅助化疗治疗浸润性乳腺癌的疗效及多药耐药蛋白表达的变化","userCount":1,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中国医科大学肿瘤医院 辽宁省肿瘤医院  张晓晶\r\n研究出处：中华肿瘤杂志, 2019,41(4) : 309-314","filepathIds":"","id":9745,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"骨与软组织肉瘤伴肺转移患者应用阿帕替尼联合化疗的临床疗效","userCount":1,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中国医学科学院肿瘤医院  李青\r\n研究出处：中华肿瘤杂志, 2019,41(5) : 368-372","filepathIds":"","id":9746,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"高复发风险早期乳腺癌患者行表阿霉素联合环磷酰胺序贯紫杉醇剂量密集辅助化疗的耐受性分析","userCount":4,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：中国医学科学院肿瘤医院  肖泽芬\r\n研究出处：中华肿瘤杂志, 2019,41(6) : 415-420","filepathIds":"","id":9747,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"局部晚期食管癌根治术后放疗同步周方案化疗的耐受性研究","userCount":1,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：江苏大学附属徐州医院　江苏省徐州市肿瘤医院  赵鸿鹰\r\n研究出处：中华肿瘤杂志, 2019,41(10) : 775-781","filepathIds":"","id":9748,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"阿帕替尼联合化疗一线治疗驱动基因阴性晚期非小细胞肺癌的临床研究","userCount":4,"userId":2483213},{"createTime":1576166047000,"description":"通讯作者：郑州大学附属肿瘤医院　河南省肿瘤医院  王慧娟\r\n研究出处：中华肿瘤杂志, 2019,41(10) : 783-791","filepathIds":"","id":9749,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"第一代表皮生长因子受体酪氨酸激酶抑制剂与含铂化疗一线治疗表皮生长因子受体罕见突变阳性晚期肺腺癌患者","userCount":2,"userId":2483213},{"createTime":1576553837000,"description":"通讯作者：中山大学肿瘤防治中心  张力\r\n研究出处：《柳叶刀·呼吸医学》Lancet Respir Med. 2019 May;7(5):437-446.","id":9760,"images":[],"isRight":0,"researchId":110097349,"researchItemId":2383,"title":"对比阿来替尼与克唑替尼在亚洲未经治疗的间变性淋巴瘤激酶阳性非小细胞肺癌患者中（ALESIA）：一项随机3期研究","userCount":3,"userId":2483213}],"researchId":110097349,"title":"请选出你心中的十大“2019 CSCO-CMT中国临床肿瘤学年度进展”（最多投10项）","userCount":409,"userId":2483213}],"itemsMap":{2383:{"isMultiple":1,"rightOptions":[]}},"joinRange":0,"mark":2,"modifyTime":1576166046000,"researchType":0,"startTime":1576166400000,"title":"2019 CSCO-CMT投票","userId":2483213,"voteCount":2}

200 评论

知情同意书

2019 CSCO-CMT中国临床肿瘤学年度进展评选活动开始啦！

热门资讯

关于我们

中国医学论坛报微信矩阵

助力乡村振兴帮扶行动

友情链接